Investigating Ex Vivo Animal Models to Test the Performance of Intravitreal Liposomal Drug Delivery Systems

There is a strong need for innovative and efficient drug delivery systems for ocular therapy development. However, testing intravitreal drug delivery systems without using live animals is challenging. Ex vivo animal models offer an interesting alternative. We analyzed the potential of using fresh po...

Full description

Bibliographic Details
Main Authors: Gustav Christensen, Leon Barut, Dileep Urimi, Nicolaas Schipper, François Paquet-Durand
Format: Article
Language:English
Published: MDPI AG 2021-07-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/13/7/1013
_version_ 1797526369614168064
author Gustav Christensen
Leon Barut
Dileep Urimi
Nicolaas Schipper
François Paquet-Durand
author_facet Gustav Christensen
Leon Barut
Dileep Urimi
Nicolaas Schipper
François Paquet-Durand
author_sort Gustav Christensen
collection DOAJ
description There is a strong need for innovative and efficient drug delivery systems for ocular therapy development. However, testing intravitreal drug delivery systems without using live animals is challenging. Ex vivo animal models offer an interesting alternative. We analyzed the potential of using fresh porcine eyes obtained from the local slaughterhouse as a model for testing the intravitreal biodistribution and retention of liposomes with or without polyethylene glycol (PEG) conjugation and with different surface charges. The histology of the eyes was analyzed to localize the liposomes, and it was found that liposomes with PEG absorbed rapidly on the retina (within 1 h), with positively charged and PEG-coated liposomes being retained for at least 24 h. In parallel, fluorophotometry was employed on intact eyes, to determine the pharmacokinetics of the fluorophore calcein, as a substitute for a small hydrophilic therapeutic compound. We found a 4.5-fold increase in the vitreous half-life of calcein loaded in liposomes, compared with the free solution. Retinal toxicity was addressed using murine-derived retinal explant cultures. Liposomes were non-toxic up to 500 µg/mL. Toxicity was observed at 5 mg/mL for anionic and cationic liposomes, with 2-fold and 2.5-fold increased photoreceptor cell death, respectively. Overall, we could show that important ocular drug delivery considerations such as pharmacokinetics and biodistribution can be estimated in ex vivo porcine eyes, and may guide subsequent in vivo experiments.
first_indexed 2024-03-10T09:28:14Z
format Article
id doaj.art-2125a8e32aba4fc4bc5b934ed27ca091
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-10T09:28:14Z
publishDate 2021-07-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-2125a8e32aba4fc4bc5b934ed27ca0912023-11-22T04:40:43ZengMDPI AGPharmaceutics1999-49232021-07-01137101310.3390/pharmaceutics13071013Investigating Ex Vivo Animal Models to Test the Performance of Intravitreal Liposomal Drug Delivery SystemsGustav Christensen0Leon Barut1Dileep Urimi2Nicolaas Schipper3François Paquet-Durand4Institute for Ophthalmic Research, University of Tübingen, Elfriede-Aulhorn Straße 5-7, 72076 Tübingen, GermanyInstitute for Ophthalmic Research, University of Tübingen, Elfriede-Aulhorn Straße 5-7, 72076 Tübingen, GermanyDivision Bioeconomy and Health, Chemical Process and Pharmaceutical Development, RISE Research Institutes of Sweden, Forskargatan 18, 151 36 Södertälje, SwedenDivision Bioeconomy and Health, Chemical Process and Pharmaceutical Development, RISE Research Institutes of Sweden, Forskargatan 18, 151 36 Södertälje, SwedenInstitute for Ophthalmic Research, University of Tübingen, Elfriede-Aulhorn Straße 5-7, 72076 Tübingen, GermanyThere is a strong need for innovative and efficient drug delivery systems for ocular therapy development. However, testing intravitreal drug delivery systems without using live animals is challenging. Ex vivo animal models offer an interesting alternative. We analyzed the potential of using fresh porcine eyes obtained from the local slaughterhouse as a model for testing the intravitreal biodistribution and retention of liposomes with or without polyethylene glycol (PEG) conjugation and with different surface charges. The histology of the eyes was analyzed to localize the liposomes, and it was found that liposomes with PEG absorbed rapidly on the retina (within 1 h), with positively charged and PEG-coated liposomes being retained for at least 24 h. In parallel, fluorophotometry was employed on intact eyes, to determine the pharmacokinetics of the fluorophore calcein, as a substitute for a small hydrophilic therapeutic compound. We found a 4.5-fold increase in the vitreous half-life of calcein loaded in liposomes, compared with the free solution. Retinal toxicity was addressed using murine-derived retinal explant cultures. Liposomes were non-toxic up to 500 µg/mL. Toxicity was observed at 5 mg/mL for anionic and cationic liposomes, with 2-fold and 2.5-fold increased photoreceptor cell death, respectively. Overall, we could show that important ocular drug delivery considerations such as pharmacokinetics and biodistribution can be estimated in ex vivo porcine eyes, and may guide subsequent in vivo experiments.https://www.mdpi.com/1999-4923/13/7/1013liposomesintravitrealocular drug deliveryretinal explants
spellingShingle Gustav Christensen
Leon Barut
Dileep Urimi
Nicolaas Schipper
François Paquet-Durand
Investigating Ex Vivo Animal Models to Test the Performance of Intravitreal Liposomal Drug Delivery Systems
Pharmaceutics
liposomes
intravitreal
ocular drug delivery
retinal explants
title Investigating Ex Vivo Animal Models to Test the Performance of Intravitreal Liposomal Drug Delivery Systems
title_full Investigating Ex Vivo Animal Models to Test the Performance of Intravitreal Liposomal Drug Delivery Systems
title_fullStr Investigating Ex Vivo Animal Models to Test the Performance of Intravitreal Liposomal Drug Delivery Systems
title_full_unstemmed Investigating Ex Vivo Animal Models to Test the Performance of Intravitreal Liposomal Drug Delivery Systems
title_short Investigating Ex Vivo Animal Models to Test the Performance of Intravitreal Liposomal Drug Delivery Systems
title_sort investigating ex vivo animal models to test the performance of intravitreal liposomal drug delivery systems
topic liposomes
intravitreal
ocular drug delivery
retinal explants
url https://www.mdpi.com/1999-4923/13/7/1013
work_keys_str_mv AT gustavchristensen investigatingexvivoanimalmodelstotesttheperformanceofintravitrealliposomaldrugdeliverysystems
AT leonbarut investigatingexvivoanimalmodelstotesttheperformanceofintravitrealliposomaldrugdeliverysystems
AT dileepurimi investigatingexvivoanimalmodelstotesttheperformanceofintravitrealliposomaldrugdeliverysystems
AT nicolaasschipper investigatingexvivoanimalmodelstotesttheperformanceofintravitrealliposomaldrugdeliverysystems
AT francoispaquetdurand investigatingexvivoanimalmodelstotesttheperformanceofintravitrealliposomaldrugdeliverysystems